Fig. 3From: Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatmentExample of planned vs post-profiling treatment costs of a patients with leiomyosarcoma. Trabectedin is calculated with £3544.77 and sunitinib 1765.58Back to article page